-
Zydus Lifesciences Q1 Results FY27: Date, Revenue Estimates and What to Expect
- June 25, 2026
- Posted by: Ankit Jaiswal
- Category: News
Zydus Lifesciences Q1 FY27: Rev Rs 6,962 Cr (+5.9%) PAT Rs 1,561 Cr (+2.6%) | Uniresearch trailing analysis.
-
Coal India Q1 Results FY27: Date, Revenue Estimates and What to Expect
- June 25, 2026
- Posted by: Ankit Jaiswal
- Category: News
Coal India Q1 FY27: Rev Rs 34,910 Cr (-2.6%) PAT Rs 7,302 Cr (-16.4%) | 24-analyst consensus.
-
Mahindra CIE Automotive Q1 Results FY27: Date, Revenue Estimates and What to Expect
- June 25, 2026
- Posted by: Ankit Jaiswal
- Category: News
Mahindra CIE Automotive Q1 FY27: Rev Rs 2,512 Cr (+5.1%) PAT Rs 203 Cr (-0.5%) | Uniresearch trailing analysis.
-
Federal Bank Q1 Results FY27: Date, Revenue Estimates
- June 25, 2026
- Posted by: Kunal Singla
- Category: News
Federal Bank Q1 FY27: Rev Rs 7,601 Cr (+6.3%) PAT Rs 864 Cr (-9.2%) | Uniresearch trailing analysis.
-
Alkem Laboratories Q1 Results FY27: Date, Revenue Estimates
- June 25, 2026
- Posted by: Kunal Singla
- Category: News
Alkem Laboratories Q1 FY27: Rev Rs 3,748 Cr (+11.2%) PAT Rs 811 Cr (+21.5%) | Uniresearch trailing analysis.
-
Phoenix Mills Q1 Results FY27: Date, Revenue Estimates
- June 25, 2026
- Posted by: Ankit Jaiswal
- Category: News
Phoenix Mills Q1 FY27: Rev Rs 1,005 Cr (+5.4%) PAT Rs 327 Cr (+1.9%) | Uniresearch trailing analysis.
-
DLF Q1 Results FY27: Date, Revenue Estimates
- June 25, 2026
- Posted by: Kunal Singla
- Category: News
DLF Q1 FY27: Rev Rs 4,076 Cr (+50.0%) PAT Rs 903 Cr (+18.3%) | Uniresearch trailing analysis.
-
Tube Investments of India Q1 Results FY27: Date, Revenue Estimates
- June 25, 2026
- Posted by: Kunal Singla
- Category: News
Tube Investments of India Q1 FY27: Rev Rs 6,157 Cr (+16.0%) PAT Rs 290 Cr (-4.4%) | Uniresearch trailing analysis.
-
Vijaya Diagnostic Share Price Up 3.3% to Rs 1,355 on Emkay Buy — Q4 FY26 PAT +37.5% to Rs 47.93 Cr, Revenue +26.6%
- June 25, 2026
- Posted by: Neeraj Pandey
- Category: News
Vijaya Diagnostic Share Price Up 3.3% to Rs 1,355 on Emkay Buy — Q4 FY26 PAT +37.5% to Rs 47.93 Cr, Revenue +26.6%.